Form 8-K Mirati Therapeutics, For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mirati Therapeutics (MRTX) Posts Q3 Loss of 64c/Share
November 10, 2014 10:00 AM ESTMirati Therapeutics (NASDAQ: MRTX) reported Q3 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Mirati Therapeutics (MRTX) click here.
... More